• ★ Maudsley Deprescribing Guide
• ★ 2026-02-29
• ★ Questions & Answers

Add Your Own Ideas, Strategies, Hints and Tricks:

Answer the questions:

How to get bonus or discount?

What is your advice for new users?

How would you rate this application?

Do you know any tricks or secrets?

Could you share a short guide and tips?

 

 

The biggest tips & tricks library, search for hack and cheat codes for top mobile games and apps.

About Maudsley Deprescribing Guide

"Try before you buy"-Download the FREE App,which contains sample content. In-App purchase needed to unblock all content.

The Maudsley Deprescribing Guidelines provide evidence-based recommendations for safely discontinuing antidepressants, benzodiazepines, gabapentinoids, and Z-drugs. This resource is essential for healthcare professionals aiming to optimize patient care and minimize medication-related harm. It emphasizes a patient-centered approach, ensuring that deprescribing is conducted thoughtfully and effectively.

The Maudsley® Deprescribing Guidelines
Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more.

Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the Globe Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to get help to do so.

The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative info on this necessary aspect of treatment.

This evidence-based handbook provides an overview of principles to be used in deprescribing. This is derived from fundamental scientific principles and the recent research on this topic, combined with emerging insights from clinical practice (including from patient experts).

Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released). The Maudsley Deprescribing Guidelines covers topics such as:

- Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugs
- Barriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation process
- Distinguishing withdrawal symptoms, such as bad mood, anxiety, insomnia, and a dozens of physical symptoms from symptoms of the underlying disorder that medication was intended to treat
- The difference between physical dependence and addiction/substance use disorder
- Explanation of why and how to implement hyperbolic tapering in clinical practice
- Specific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approaches
- Step-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for every drug, and guidance on how to tailor these to an individual
- Troubleshooting problems which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse.
- Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.

Content licensed from printed ISBN 10: 1119823021
Content licensed from printed ISBN 13: 9781119823025

If you have any questions or comments,email us any time:customersupport@skyscape.com or call 508-299-3000
Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms & Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Author:Deanna Tag Horowitz; David M. Taylor
Publisher:Wiley-Blackwell

New Features:

Maudsley Deprescribing Guide Cheats, Hints, Way to Modify, How to Use & How to Win.